126 related articles for article (PubMed ID: 26771605)
21. Calpain restrains the stem cells compartment in breast cancer.
Raimondi M; Marcassa E; Cataldo F; Arnandis T; Mendoza-Maldonado R; Bestagno M; Schneider C; Demarchi F
Cell Cycle; 2016; 15(1):106-16. PubMed ID: 26771715
[TBL] [Abstract][Full Text] [Related]
22. Investigating Cutaneous Squamous Cell Carcinoma
Quadri M; Marconi A; Sandhu SK; Kiss A; Efimova T; Palazzo E
Front Med (Lausanne); 2022; 9():875517. PubMed ID: 35646967
[TBL] [Abstract][Full Text] [Related]
23. Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?
Palazzo E; Marconi A; Pincelli C; Morasso MI
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331058
[TBL] [Abstract][Full Text] [Related]
24. Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma.
Goldie SJ; Chincarini G; Darido C
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060263
[TBL] [Abstract][Full Text] [Related]
25. HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development.
Zhou L; Wang Y; Zhou M; Zhang Y; Wang P; Li X; Yang J; Wang H; Ding Z
Nat Commun; 2018 Apr; 9(1):1480. PubMed ID: 29662084
[TBL] [Abstract][Full Text] [Related]
26. p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response.
Arcidiacono P; Webb CM; Brooke MA; Zhou H; Delaney PJ; Ng KE; Blaydon DC; Tinker A; Kelsell DP; Chikh A
Nat Commun; 2018 Mar; 9(1):1021. PubMed ID: 29523849
[TBL] [Abstract][Full Text] [Related]
27. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.
Khan Z; Khan AA; Yadav H; Prasad GBKS; Bisen PS
Cell Mol Biol Lett; 2017; 22():8. PubMed ID: 28536639
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway.
Chen S; Sun YY; Zhang ZX; Li YH; Xu ZM; Fu WN
Oncotarget; 2017 Feb; 8(9):14708-14718. PubMed ID: 28122350
[TBL] [Abstract][Full Text] [Related]
29. Stem Cell Activation in Adult Organisms.
Bloch W
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347939
[TBL] [Abstract][Full Text] [Related]
30. Long-Lived Epidermal Cancer-Initiating Cells.
Youssef M; Cuddihy A; Darido C
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28654000
[TBL] [Abstract][Full Text] [Related]
31. Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival.
Albor A; Kulesz-Martin M
Mol Carcinog; 2007 Aug; 46(8):585-90. PubMed ID: 17626251
[TBL] [Abstract][Full Text] [Related]
32. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo.
Lotti R; Palazzo E; Petrachi T; Dallaglio K; Saltari A; Truzzi F; Quadri M; Puviani M; Maiorana A; Marconi A; Pincelli C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771605
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of squamous cell carcinoma-derived stem-like cells: role in tumor formation.
Dallaglio K; Petrachi T; Marconi A; Truzzi F; Lotti R; Saltari A; Morandi P; Puviani M; Maiorana A; Roop DR; Pincelli C
Int J Mol Sci; 2013 Sep; 14(10):19540-55. PubMed ID: 24077125
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia promotes radioresistance of CD133-positive Hep-2 human laryngeal squamous carcinoma cells in vitro.
Wang M; Li X; Qu Y; Xu O; Sun Q
Int J Oncol; 2013 Jul; 43(1):131-40. PubMed ID: 23652853
[TBL] [Abstract][Full Text] [Related]
35. Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133
Quan XX; Hawk NV; Chen W; Coupar J; Lee SK; Petersen DW; Meltzer PS; Montemarano A; Braun M; Chen Z; Van Waes C
Mol Cancer Ther; 2018 Sep; 17(9):2034-2048. PubMed ID: 29959199
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
